Cargando…
Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review
BACKGROUND: Erythropoiesis-stimulating agents (ESAs) revolutionized the management of anaemia in chronic kidney disease (CKD) when introduced in the late 1980s. A range of ESA types, preparations and administration modalities now exist, with newer agents requiring less frequent administration. Altho...
Autores principales: | Bruce, Gordon, Schulga, Peter, Reynolds, Ben C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308099/ https://www.ncbi.nlm.nih.gov/pubmed/35892014 http://dx.doi.org/10.1093/ckj/sfac058 |
Ejemplares similares
-
Chronic kidney disease in children: an update
por: Cirillo, Luigi, et al.
Publicado: (2023) -
Deprivation and chronic kidney disease—a review of the evidence
por: Grant, Christopher H, et al.
Publicado: (2023) -
Gluconeogenesis in the kidney: in health and in chronic kidney disease
por: Dalga, Delal, et al.
Publicado: (2023) -
Ultraprocessed foods and chronic kidney disease—double trouble
por: Avesani, Carla Maria, et al.
Publicado: (2023) -
Coronavirus disease 2019 in chronic kidney disease
por: D’Marco, Luis, et al.
Publicado: (2020)